HEADLINES: Tiaji turns to Grey to promote anti-obesity drug

<p>China's state-owned Tiaji Group has signed on Grey Worldwide: </p><p>Shanghai to boost the brand profile for its anti-obesity drug, Qumei, </p><p>which it launched in July 2000. </p><p><BR><BR> </p><p>Grey's appointment marks the first time that the 21-year-old </p><p>pharmaceutical group, which is listed on the Shanghai stock exchange and </p><p>last year hit annual sales of Rmb 2 billion (USdollars 242 million), is </p><p>using a multinational 4A's agency to work on its brands. </p><p><BR><BR> </p>

China's state-owned Tiaji Group has signed on Grey Worldwide:

Shanghai to boost the brand profile for its anti-obesity drug, Qumei,

which it launched in July 2000.



Grey's appointment marks the first time that the 21-year-old

pharmaceutical group, which is listed on the Shanghai stock exchange and

last year hit annual sales of Rmb 2 billion (USdollars 242 million), is

using a multinational 4A's agency to work on its brands.